Delivery Order SPE2DR25D2014-SPE2DR26FA1R5
- Not listed
- On January 8, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,189.43 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors with 0.5 mL dosage units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 9, 2026, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made on a full and open competitive basis with no set-aside designation....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 2, 2026, by the Defense Logistics Agency for the supply of Trulicity 0.75 mg/0.5 ml pens valued at $1,424.16. The award represents a competitive, non-set-aside contract with firm fixed pricing and is scheduled for completion by January 5, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $1,435.89. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors valued at $1,218.01, with completion scheduled for August 22, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical transaction within the broader federal medical supply chain. The contract specifies performance at AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, where the...
- On January 7, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,106.56 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pen injectors. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to a location in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. AmerisourceBergen Drug Corp, a subsidiary of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $2,026.98. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The contract is scheduled for completion by October 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections with a ceiling value of $2,372.39. This is a firm fixed-price delivery order with an ultimate completion date of November 4, 2025, and represents a non-set-aside competitive award. The order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors valued at $6,767.36. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of November 21, 2025. The order is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $7,079.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp (a subsidiary of parent company Cencora, Inc.) on January 6, 2026, for the supply of Trulicity 0.75 mg/0.5 ml pen injections. The contract is non-set-aside and was competitively awarded, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, by January 7, 2026. This delivery order represents a task order issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a $1,067.17 delivery order on November 20, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 0.75 mg/0.5 mL pen injections. This firm fixed-price contract is non-competitive with no set-aside designation and carries an ultimate completion date of November 21, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA1R5Delivery Order
On January 7, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,265.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 8, 2026 and performance to be executed in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. and serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) vehicle held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The IDC serves as a comprehensive global pharmaceutical support mechanism enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The competitive award of this delivery order reflects AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/6/26 |